Corning, Elanco, Citigroup: CNBC's 'Final Trades'
$C
$ELAN
$GLW
Major Banks
Finance
Biotechnology: Pharmaceutical Preparations
Health Care
- CNBC
- CNBC
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 9/19/2024 | $17.00 → $15.00 | Overweight → Equal-Weight | Morgan Stanley | |
| 8/21/2024 | $44.00 → $47.00 | Neutral → Outperform | Mizuho | |
| 7/31/2024 | $46.00 | Hold → Buy | Deutsche Bank | |
| 7/9/2024 | $37.00 | Reduce → Hold | HSBC Securities | |
| 6/17/2024 | $45.00 | Equal Weight → Overweight | Fox Advisors | |
| 6/13/2024 | $35.00 → $38.00 | Overweight → Equal-Weight | Morgan Stanley | |
| 5/30/2024 | $37.00 → $43.00 | Neutral → Overweight | JP Morgan | |
| 5/7/2024 | $36.00 | Neutral | Mizuho |
GREENFIELD, Ind., Nov. 15, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today acquired a contract manufacturing facility and related assets in Speke, UK. The facility, previously owned by TriRx Speke Ltd., was under trading administration, a formal insolvency process in the United Kingdom. As previously shared on the Company's third quarter 2024 earnings call, the Speke facility plays a vital role for Elanco in producing a number of farm animal product lines, representing approximately $160 million to $180 million in annual farm animal revenue, primarily
Today, Citi (NYSE:C) and Bank of Shanghai launched a first-of-its-kind payments solution on Bank of Shanghai's TourCard. The TourCard aims to provide international travelers a straightforward, cost-efficient and more streamlined Chinese yuan renminbi (CNY) payment journey while traveling in China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241112572734/en/ The payment service is facilitated by Citi's industry-leading USD Clearing solution and its full-value transfers, which ensures the final beneficiary receives their money at full value with no deductions. The innovation helps enable travelers to add funds to their TourCard
Ma brings deep manufacturing and innovation expertise GREENFIELD, Ind., Nov. 12, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the appointment of Dr. Stacey Ma to its Board of Directors, effective immediately. Dr. Ma brings extensive global leadership experience in biopharmaceutical development and manufacturing, further strengthening Elanco's expertise in these critical areas. "We are delighted to add Stacey to the Elanco Board," said Lawrence Kurzius, Chairman of the Elanco Board of Directors. "Her deep understanding of product developmen
SC 13G - CITIGROUP INC (0000831001) (Filed by)
SC 13G/A - CORNING INC /NY (0000024741) (Subject)
SC 13G/A - Elanco Animal Health Inc (0001739104) (Subject)
Morgan Stanley downgraded Elanco Animal Health from Overweight to Equal-Weight and set a new price target of $15.00 from $17.00 previously
Mizuho upgraded Corning from Neutral to Outperform and set a new price target of $47.00 from $44.00 previously
Deutsche Bank upgraded Corning from Hold to Buy and set a new price target of $46.00
Ma brings deep manufacturing and innovation expertise GREENFIELD, Ind., Nov. 12, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the appointment of Dr. Stacey Ma to its Board of Directors, effective immediately. Dr. Ma brings extensive global leadership experience in biopharmaceutical development and manufacturing, further strengthening Elanco's expertise in these critical areas. "We are delighted to add Stacey to the Elanco Board," said Lawrence Kurzius, Chairman of the Elanco Board of Directors. "Her deep understanding of product developmen
Mubadala and Athene to Participate as Apollo Strategic Partner and Affiliate, Respectively Citi & Apollo Private Credit, Direct Lending Program Marks Largest Relationship of its Kind Citigroup Inc. (NYSE:C) and Apollo (NYSE:APO) today announced that they have entered into an exclusive agreement for a subsidiary of Citi and certain affiliates of Apollo to form a landmark $25 billion private credit, direct lending program initially in North America, with the potential to expand to additional geographies. The program will include participation from Mubadala Investment Company as Apollo's strategic partner as well as Apollo's subsidiary, Athene, both of which will have the opportunity to join
EV Infrastructure Disruptor to Join Premier Gathering of World Leaders During the UN General Assembly Week in New York City EVPassport, a global EV charging network, today announced that CEO Hooman Shahidi will speak at the 2024 Concordia Annual Summit, a premier gathering of public and private sector visionaries during the UN General Assembly week, happening September 23-25, in New York City. Shahidi, a longtime proponent of using technology to drive good, will be joined on stage by other public and private sector visionaries to discuss advancing environmental sustainability through technological innovation that drives both business and consumer benefits. This press release features multi
4 - Elanco Animal Health Inc (0001739104) (Issuer)
4 - Elanco Animal Health Inc (0001739104) (Issuer)
4 - Elanco Animal Health Inc (0001739104) (Issuer)
GREENFIELD, Ind., Nov. 15, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today acquired a contract manufacturing facility and related assets in Speke, UK. The facility, previously owned by TriRx Speke Ltd., was under trading administration, a formal insolvency process in the United Kingdom. As previously shared on the Company's third quarter 2024 earnings call, the Speke facility plays a vital role for Elanco in producing a number of farm animal product lines, representing approximately $160 million to $180 million in annual farm animal revenue, primarily
Results were at the high end of guidance, led by Optical Communications, which grew sales in its Enterprise business 55% year over year, driven by continued strong adoption of new optical-connectivity products for generative AI GAAP operating margin expanded 150 bps year over year; core operating margin expanded 160 bps year over year to 18.3%, marking significant progress on ‘Springboard' target of 20% by the end of 2026 Display Technologies implemented price increases and expects to deliver segment net income of $900 million to $950 million in 2025 and to maintain net income margin of 25% In the fourth quarter, management expects year-over-year sales growth to accelerate and EPS to gro
The Board of Directors of Citigroup Inc. today declared a quarterly dividend on Citigroup's common stock of $0.56 per share, payable on November 22, 2024, to stockholders of record on November 4, 2024. The Board of Directors of Citigroup Inc. also declared dividends on Citigroup's preferred stock as follows: – 5.950% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series P, payable November 15, 2024, to holders of record on November 5, 2024. Holders of depositary receipts, each representing one-twenty-fifth of a full preferred share, will be paid $29.75 for each receipt held. – 4.000% Fixed Rate Reset Noncumulative Preferred Stock, Series W, payable December 10, 2024, to holders
Delta Air Lines Inc (NYSE:DAL) is about to face significant financial repercussions this quarter due to a recent system failure that resulted in thousands of flight cancellations and triggered a federal investigation into the airline’s response. Citigroup Inc (NYSE:C) reduced its estimates for Delta's third-quarter adjusted earnings by 60 cents per share to $1.37, citing increased operational expenses and potential customer compensation costs, reported Bloomberg. Analyst Stephen Trent also cut two profit metrics by approximately $500 million each. The financial setback adds to Delta’s woes as flight disruptions start to subside. Delta CEO Ed Bastian stated on Wednesday cancellations
On CNBC's “Halftime Report Final Trades,” Kevin Simpson of Capital Wealth Planning said Honeywell International Inc. (NASDAQ:HON) bought back 10% of their float over the last five years. Honeywell will release its second-quarter financial results, before the opening bell on Thursday, July 25. Analysts expect the Charlotte, North Carolina-based company to report quarterly earnings at $2.41 per share, up from $2.23 per share in the year-ago period. Honeywell is seen posting revenue of $9.41 billion, compared to $9.17 billion a year earlier, according to data from Benzinga Pro. Don't forget to check out our premarket coverage here Joshua Brown of Ritholtz Wealth Management said Corning
Whales with a lot of money to spend have taken a noticeably bullish stance on Citigroup. Looking at options history for Citigroup (NYSE:C) we detected 15 trades. If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 46% with bearish. From the overall spotted trades, 7 are puts, for a total amount of $1,026,718 and 8, calls, for a total amount of $1,799,454. Predicted Price Range After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $72.5 for Citigroup, spanning the last three months. Volume & Open Interest Development L
4 - CORNING INC /NY (0000024741) (Issuer)
4 - Elanco Animal Health Inc (0001739104) (Issuer)
4 - Elanco Animal Health Inc (0001739104) (Issuer)
FWP - CITIGROUP INC (0000831001) (Subject)
FWP - CITIGROUP INC (0000831001) (Subject)
FWP - CITIGROUP INC (0000831001) (Subject)